ImageVerifierCode 换一换
格式:PDF , 页数:14 ,大小:175.07KB ,
资源ID:572196      下载积分:10000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-572196.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(BS EN 14136-2004 Use of external quality assessment schemes in the assessment of the performance of in vitro diagnostic examination procedures《体外诊断检验程序的性能评定中外部质量评定方案的使用》.pdf)为本站会员(Iclinic170)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

BS EN 14136-2004 Use of external quality assessment schemes in the assessment of the performance of in vitro diagnostic examination procedures《体外诊断检验程序的性能评定中外部质量评定方案的使用》.pdf

1、BRITISH STANDARD BS EN 14136:2004 Use of external quality assessment schemes in the assessment of the performance of in vitro diagnostic examination procedures The European Standard EN 14136:2004 has the status of a British Standard ICS 11.100 BS EN 14136:2004 This British Standard was published und

2、er the authority of the Standards Policy and Strategy Committee on 26 May 2004 BSI 26 May 2004 ISBN 0 580 43819 8 National foreword This British Standard is the official English language version of EN 14136:2004. The UK participation in its preparation was entrusted to Technical Committee CH/212, IV

3、Ds, which has the responsibility to: A list of organizations represented on this committee can be obtained on request to its secretary. Cross-references The British Standards which implement international or European publications referred to in this document may be found in the BSI Catalogue under t

4、he section entitled “International Standards Correspondence Index”, or by using the “Search” facility of the BSI Electronic Catalogue or of British Standards Online. This publication does not purport to include all the necessary provisions of a contract. Users are responsible for its correct applica

5、tion. Compliance with a British Standard does not of itself confer immunity from legal obligations. aid enquirers to understand the text; present to the responsible international/European committee any enquiries on the interpretation, or proposals for change, and keep the UK interests informed; moni

6、tor related international and European developments and promulgate them in the UK. Summary of pages This document comprises a front cover, an inside front cover, the EN title page, pages 2 to 11 and a back cover. The BSI copyright notice displayed in this document indicates when the document was las

7、t issued. Amendments issued since publication Amd. No. Date CommentsEUROPEANSTANDARD NORMEEUROPENNE EUROPISCHENORM EN14136 May2004 ICS11.100 Englishversion Useofexternalqualityassessmentschemesintheassessment oftheperformanceofinvitrodiagnosticexaminationprocedures Utilisationdesprogrammesdvaluation

8、externedela qualitdanslvaluationdelaperformancedesprocdures dediagnosticinvitro VerwendungexternerQualittssicherungsprogrammebei derBewertungderDurchfhrungvon UntersuchungsverfahreninderInvitroDiagnostik ThisEuropeanStandardwasapprovedbyCENon2March2004. CENmembersareboundtocomplywiththeCEN/CENELECIn

9、ternalRegulationswhichstipulatetheconditionsforgivingthisEurope an Standardthestatusofanationalstandardwithoutanyalteration.Uptodatelistsandbibliographicalreferencesconcernings uchnational standardsmaybeobtainedonapplicationtotheCentralSecretariatortoanyCENmember. ThisEuropeanStandardexistsinthreeof

10、ficialversions(English,French,German).Aversioninanyotherlanguagemadebytra nslation undertheresponsibilityofaCENmemberintoitsownlanguageandnotifiedtotheCentralSecretariathasthesamestatusast heofficial versions. CENmembersarethenationalstandardsbodiesofAustria,Belgium,Cyprus,CzechRepublic,Denmark,Esto

11、nia,Finland,France, Germany,Greece,Hungary,Iceland,Ireland,Italy,Latvia,Lithuania,Luxembourg,Malta,Netherlands,Norway,Poland,Portugal, Slovakia, Slovenia,Spain,Sweden,SwitzerlandandUnitedKingdom. EUROPEANCOMMITTEEFORSTANDARDIZATION COMITEUROPENDENORMALISATION EUROPISCHESKOMITEEFRNORMUNG ManagementCe

12、ntre:ruedeStassart,36B1050Brussels 2004CEN Allrightsofexploitationinanyformandbyanymeansreserved worldwideforCENnationalMembers. Ref.No.EN14136:2004:EEN14136:2004(E) 2 Foreword Thisdocument(EN14136:2004)hasbeenpreparedbyTechnicalCommitteeCEN/TC140“Invitrodiagnostic medicaldevices”,thesecretariatofwh

13、ichisheldbyDIN. ThisEuropeanStandardshallbegiventhestatusofanationalstandard,eitherbypublicationofanidenticaltextor byendorsement,atthelatestbyNovember2004,andconflictingnationalstandardsshallbewithdrawnatthelatest byNovember2004. ThisdocumenthasbeenpreparedunderamandategiventoCENbytheEuropeanCommis

14、sionandtheEuropean FreeTradeAssociation,andsupportsessentialrequirementsofEUDirective(s). ForrelationshipwithEUDirective(s),seeinformativeAnnexZA,whichisanintegralpartofthisdocument. ThisdocumentincludesaBibliography. AccordingtotheCEN/CENELECInternalRegulations,thenationalstandardsorganizationsofth

15、efollowing countriesareboundtoimplementthisEuropeanStandard:Austria,Belgium,Cyprus,CzechRepublic,Denmark, Estonia,Finland,France,Germany,Greece,Hungary,Iceland,Ireland,Italy,Latvia,Lithuania,Luxembourg,Malta, Netherlands,Norway,Poland,Portugal,Slovakia,Slovenia,Spain,Sweden,SwitzerlandandUnitedKingd

16、om.EN14136:2004(E) 3 Introduction Externalqualityassessmentschemes(EQAS)areanessentialfeatureofmechanismsdesignedtomaintainand improvetheanalyticalqualityandmedicalappropriatenessofclinicallaboratorydata.EQASaremosthighly developedinfieldsinwhichmostlyquantitative,numericaldataaregenerated;notablyin

17、clinicalchemistry, haematology,immunology,etc.However,EQAScanalsobeextendedtoqualitativeormoresubjective investigationssuchasinmicrobiologyandparasitology,aswellasinhistoorcytopathology. ParticipationandacceptableperformanceinEQASserveavaluablefunctioninraisingstandardsinlaboratory medicineandineduc

18、atingprovidersandusersaboutthepotentialbenefitsandlimitationsoflaboratory examinations.ObjectivedataprovidedbyEQASareanessentialcomponentofeffortstorelatethecurrentstateof theartoflaboratoryperformancetomedicalneeds. EQASarealreadyessentialpartsoflaboratoryaccreditationsystems,whethermandatoryornot,

19、inmemberstates oftheEuropeanUnion.Goodclinicallaboratorypracticeincludesbothexternalqualityassessmentandinternal qualitycontrolascomplementarycomponentsofqualityassurance. InadditiontothemajorobjectivesofEQAS(seeISO/IEC Guide 431),datafromEQAScanalsoprovidea valuableresourceinenablingcomparisonstobe

20、madebetweenalternativeneworestablishedanalytical procedures(includinginvitrodiagnosticmedicaldeviceshereaftercalledIVD MDs),orindemonstratingthe transferabilityofproceduresbetweenlaboratories,orindisclosingdifficultiesordeficienciesintheiroperationthat canonlybecomeapparentduringlongtermandwidesprea

21、duse.AnEQASinwhichthesurveysampleshave referenceprocedurevaluescanprovideevidenceofthetruenessofresultsobtainedbyusingdifferentprocedures; anEQASinwhichthesamesurveysamplesarecirculatedrepeatedlyandfrequentlycandemonstrate reproducibilityand,e.g.,thepossibleeffectsofchangesinthepropertiesofanIVDMD.

22、ThemajorobjectivesofindividualEQASdiffer,rangingfromthosethataredirectedprincipallytowardsensuring compliancewithspecificproficiencytargets,tothosethatareaimedatageneralsurveyandimprovementof particularservices:e. g.,indevelopinganetworkofparticipation,orinestablishingcriteriaforevaluating performan

23、ceofmoresubjectiveinvestigations.Thus,detailsofschemessuchasorganisation(e.g.,byregulatory authorities,professionalsocietiesorindustrialconcerns),natureandfrequencyofsampledistribution,and assessmentofresults,differfromoneschemetoanother. BecauseofthedifferingfunctionsandobjectivesofEQAS,itisneither

24、possiblenordesirabletoimposeasingle patternoforganisationonallsuchschemes,andthisEuropeanStandarddoesnotintendtodoso.Thegeneral principlesforthedesignandtheoperationofEQASareoutlinedinISO/IECGuide431andinclude: useofappropriatesurveysamples; effectivedistributiontoparticipants(e.g.laboratoriesand/or

25、pointofcaretestingsites); rapidprocessingofsurveydata; returntoparticipantsofreportsthatareclearlyinterpretedwithrespecttostatedcriteria; mechanismsforfollowupofunsatisfactoryperformance(e.g.throughadviceservices). InordertoenableEQAStoprovidedatathatareusefulinmonitoringtheanalyticalperformanceofsp

26、ecific procedures(includingIVDMDs),additionalfeaturesareused.Forexample,EQASshouldunequivocally identifyindividualprocedures(devices)usedinstatisticallysignificantnumbers,andaboveall,they shouldbeabletodistinguishperformancecharacteristicsinherentinaparticularprocedure(device)from thoseattributablet

27、oitsusers. ThisEuropeanStandardspecifieswaysinwhichEQAScanmeettheseprocedure(device)relatedcriteria.Thus, EQASisabletocontributetothepostmarketingmonitoringofIVDMDsasmentionedinDirective98/79/EConin vitrodiagnosticmedicaldevicestothebenefitofboththeirmanufacturersandusers.EN14136:2004(E) 4 1Scope Th

28、isEuropeanStandardappliestoexternalqualityassessmentschemes,hereaftercalledEQAS,thatincludein theirfunctionstheassessmentandevaluationoftheperformanceofspecifiedinvitrodiagnosticprocedures (includinginvitrodiagnosticmedicaldevices,hereaftercalledIVDMDs).Itsetsouttherequirementsthatare necessarytoena

29、bleEQAStofulfilthisfunctionrelatingto: schemedesignandorganisation; identificationofprocedures(IVDMDs)usedbytheparticipant; classificationandevaluationofdata. NOTE Externalqualityassessmentdatageneratedaccordingtothesecriteriawillhelpmanufacturers,usersorcompetent authoritiestomonitorindependentlyth

30、epostmarketingperformanceofIVDMDs. ThisEuropeanStandarddoesnotspecifywaysinwhichEQASthemselvesareorganised,norhowtheindividualor collectiveperformanceofclinicallaboratoriesisevaluated. 2 Normativereferences ThisEuropeanStandardincorporatesbydatedorundatedreference,provisionsfromotherpublications.The

31、se normativereferencesarecitedattheappropriateplacesinthetext,andthepublicationsarelistedhereafter.For datedreferences,subsequentamendmentstoorrevisionsofanyofthesepublicationsapplytothisEuropean Standardonlywhenincorporatedinitbyamendmentorrevision.Forundatedreferencesthelatesteditionofthe publicat

32、ionreferredtoapplies(includingamendments). EN375:2001, Informationsuppliedbythemanufacturerwithinvitrodiagnosticreagentsforprofessionaluse. EN12286:1998, InvitrodiagnosticmedicaldevicesMeasurementofquantitiesinsamplesofbiologicalorigin Presentationofreferencemeasurementprocedures. EN45003:1995, Cali

33、brationandtestinglaboratoryaccreditationsystemGeneralrequirementsforoperationand recognition. ENISO15195 ,LaboratorymedicineRequirementsforreferencemeasurementlaboratories(ISO/FDIS 15195:2003). ENISO17511, InvitrodiagnosticmedicaldevicesMeasurementofquantitiesinbiologicalsamplesMetrological traceabi

34、lityofvaluesassignedtocalibratorsandcontrolmaterials(ISO17511:2003). ENISO18153, InvitrodiagnosticmedicaldevicesMeasurementofquantitiesinbiologicalsamplesMetrological traceabilityofvaluesforcatalyticconcentrationofenzymesassignedtocalibratorsandcontrolmaterials(ISO 18153:2003). ISO35341:1993, Statis

35、ticsVocabularyandsymbolsPart1:Probabilityandgeneralstatisticalterms. InternationalVocabularyofBasicandGeneralTermsinMetrology(VIM),2ndedition,Geneva:ISO,1993 3 Termsanddefinitions ForthepurposesofthisEuropeanStandard,thetermsanddefinitionsgiveninEN375:2001,EN12286:1998, ENISO17511:2003,EN45003:1995,

36、ISO35341:1993,theInternationalVocabularyofBasicandGeneralTerms inMetrology(VIM)andthefollowingapply.EN14136:2004(E) 5 3.1 assignedvalue valueattributedtoaparticularquantityandaccepted,sometimesbyconvention,ashavinganuncertainty appropriateforagivenpurposeISO/IECGuide431:1997 3.2 externalqualityasses

37、sment EQA determinationofindividualandcollectivelaboratoryperformance,andperformancecharacteristicsofexamination proceduresbymeansofinterlaboratorycomparison NOTE TheprimaryobjectivesofEQAareeducational,andcanbesupportedbyadditionalelements. 3.3 nominalscale scalewithasetofpossiblevalues,foragivenki

38、ndofproperty,thatareeachdesignatedbyawordorsymbol withoutanyrelationtomagnitude EXAMPLE Bloodgroup(A,B,AB,0) NOTE Thevaluescanbelistedinanyarbitraryorderaccordingtopracticalconsiderationsandconvention. 3.4 ordinalscale scalewithanorderedsetofpossiblevalues,forpropertiesofagivenkindofproperty,thatare

39、eachdesignatedby awordorsymbolusedforrankingaccordingtomagnitude,butwheredifferencesorratiosbetweenvalueshaveno arithmeticmeaning EXAMPLES Wordingsuchas“notdetected“,“weaklypositive“,“positive“,“stronglypositive“orfiguressuchas0,1,2,3. 3.5 targetvalue acceptedreferencevalue NOTE Examplesoftargetvalu

40、esareassignedvalues,referenceprocedurevalues,andconsensusvalues. 3.6 referencemeasurementprocedure thoroughlyinvestigatedmeasurementprocedureshowntoyieldvalueshavinganuncertaintyofmeasurement commensuratewithitsintendeduse,especiallyinassessingthetruenessofothermeasurementproceduresforthe samequanti

41、tyandincharacterizingreferencematerialsEN12286:1998,3.7 3.7 referenceprocedurevalue valueobtainedbyareferencemeasurementprocedure 3.8 surveysample samplesenttoparticipantsforselectedexamination,wheretheresultisreturnedtotheEQASorganisationfor independentassessmentofperformance 4 Designrequirementsfo

42、rEQAS 4.1 TheEQASorganisationshallformulatetheobjectivesofitssurveysatitsstart. 4.2 TheEQASorganisationshallprovidesurveysamplescomposedinsuchawaythattheysimulateasclosely aspossibletherelevantpropertiesofthesamplesonwhichtheexaminationproceduresareintendedtobeused. NOTE1 Forassigningtargetvaluestos

43、urveysamplesseeENISO17511.EN14136:2004(E) 6 NOTE2 Forsomeevaluationsitcanbeappropriatetouseasetofsurveysampleswithdifferenttargetvalues. NOTE3 TheresponsibilityoftheEQASorganisationforprovidingsurveysampleswithappropriatepropertiesissetoutin ISO/IECGuide431. NOTE 4 EQASorganisationsshouldnotselectsurveysamplescontainingunphysiologicaladditiveswhichmay disadvantageanindividualIVDMD. 4.3 Thefrequencyofsurveysshallbeappropriatefortheinvestigation,andpreferablyatleast6timesperyear. InordertoallowevaluationofrecentIVDMDperformancethesurveydatashallbe

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1